Sendra, L.; Olivera, G.G.; López-Andújar, R.; Serrano, C.; Rojas, L.E.; Montalvá, E.M.; Herrero, M.J.; Aliño, S.F.
Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics 2022, 14, 354.
https://doi.org/10.3390/pharmaceutics14020354
AMA Style
Sendra L, Olivera GG, López-Andújar R, Serrano C, Rojas LE, Montalvá EM, Herrero MJ, Aliño SF.
Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics. 2022; 14(2):354.
https://doi.org/10.3390/pharmaceutics14020354
Chicago/Turabian Style
Sendra, Luis, Gladys G. Olivera, Rafael López-Andújar, Cristina Serrano, Luis E. Rojas, Eva MarÃa Montalvá, MarÃa José Herrero, and Salvador F. Aliño.
2022. "Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up" Pharmaceutics 14, no. 2: 354.
https://doi.org/10.3390/pharmaceutics14020354
APA Style
Sendra, L., Olivera, G. G., López-Andújar, R., Serrano, C., Rojas, L. E., Montalvá, E. M., Herrero, M. J., & Aliño, S. F.
(2022). Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics, 14(2), 354.
https://doi.org/10.3390/pharmaceutics14020354